| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.21 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |